BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26580456)

  • 1. What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?
    de Leon J; Spina E
    Expert Rev Clin Pharmacol; 2016; 9(3):351-4. PubMed ID: 26580456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic testing in psychiatry: not (quite) ready for primetime.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2014 Nov; 52(11):13-6. PubMed ID: 25375387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Providing patients with information on pharmacogenetic testing.
    Fleeman N; Dickson R
    Nurs Stand; 2009 Jan 28-Feb 3; 23(21):46-8. PubMed ID: 19248450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic Testing: Why Is It So Disappointing?
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2019 Apr; 57(4):9-12. PubMed ID: 30933297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic testing in psychiatry: a review of features and clinical realities.
    de Leon J; Arranz MJ; RuaƱo G
    Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
    Fan M; Bousman CA
    Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories.
    Higgs J; Gambhir N; Ramsden SC; Poulton K; Newman WG
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):121-5. PubMed ID: 20039783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.
    Pai SA; Kshirsagar N
    J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and regulatory considerations in pharmacogenetic testing.
    Schuck RN; Marek E; Rogers H; Pacanowski M
    Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing.
    Levy KD; Pratt VM; Skaar TC; Vance GH; Flockhart DA
    J Clin Pharmacol; 2015 Jul; 55(7):725-7. PubMed ID: 26053647
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetics in drug regulation: promise, potential and pitfalls.
    Shah RR
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1617-38. PubMed ID: 16096112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA perspectives on pharmacogenetic testing.
    Harper CC; Philip R; Robinowitz M; Gutman SI
    Expert Rev Mol Diagn; 2005 Sep; 5(5):643-8. PubMed ID: 16149867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Marketing and Use of Pharmacogenetic Tests for Psychiatric Treatment.
    Zubenko GS; Sommer BR; Cohen BM
    JAMA Psychiatry; 2018 Aug; 75(8):769-770. PubMed ID: 29799933
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic monitoring of psychotropic drugs and pharmacogenetic tests in psychiatry].
    Voirol P; Eap CB; Baumann P
    Rev Med Suisse Romande; 2000 Feb; 120(2):99-104. PubMed ID: 10748694
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochrome P450 genotype-guided drug therapies: An update on current states.
    Dong AN; Tan BH; Pan Y; Ong CE
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):991-1001. PubMed ID: 29858511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care.
    Hillebrenner E; Litwack E; Bradley P; Donigan K; Lowe T; Serrano K; Kelm K; Mansfield E; Gutierrez A
    J Clin Pharmacol; 2015 Jul; 55(7):728-30. PubMed ID: 26053648
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AmpliChip CYP450 test: personalized medicine has arrived in psychiatry.
    de Leon J
    Expert Rev Mol Diagn; 2006 May; 6(3):277-86. PubMed ID: 16706732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive perception of pharmacogenetic testing for psychotropic medications.
    Lanktree MB; Zai G; Vanderbeek LE; Giuffra DE; Smithson DS; Kipp LB; Dalseg TR; Speechley M; Kennedy JL
    Hum Psychopharmacol; 2014 May; 29(3):287-91. PubMed ID: 24604560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.